First innovative screens using stem cells to identify drugs for myotonic dystrophy, DM1 disease

Four research teams of I-Stem have joined forces in a collaborative project that has just achieved a first pilot therapy-oriented screen of compounds and RNA interference aiming at reversing the altered phenotypes observed in human embryonic stem cells carrying the mutant gene for myotonic dystrophy type 1. This assay inaugurates a series of R&D planned in 2009.

 

<< Return to the section “Press releases”